Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by National Resilience, Inc.

Resilience Secures Funding to Expand Domestic Manufacturing for Critical Pharmaceutical Ingredients
From National Resilience, Inc.
Via Business Wire
Resilience Appoints Dr. Susan Billings, Chief Commercial Officer
From National Resilience, Inc.
Via Business Wire
Resilience Expands Clinical and Commercial Drug Product Manufacturing Capabilities and Capacities
From National Resilience, Inc.
Via Business Wire
National Resilience and Taiwan Bio-Manufacturing Corporation Announce Groundbreaking Partnership in Biomanufacturing Innovation
From National Resilience, Inc.
Via Business Wire
Resilience to Present at the 42nd Annual J.P. Morgan Healthcare Conference
From National Resilience, Inc.
Via Business Wire
Resilience Appoints Bill Marth as President of Services
From National Resilience, Inc.
Via Business Wire
BridgeBio and Resilience Announce Strategic Multi-Year Partnership to Advance BBP-631, BBP-812 and Future Gene Therapy Treatments
From National Resilience, Inc.
Via Business Wire
Tickers BBIO
Resilience Announces Joint Venture with Lifera to Develop Manufacturing Facility in Saudi Arabia
From National Resilience, Inc.
Via Business Wire
Resilience Approved for $410M Financing from the Department of Defense, in Partnership with the Development Finance Corporation, to Establish Resilient Biomanufacturing Capacity
From National Resilience, Inc.
Via Business Wire
Resilience Signs Multi-Year Strategic Biomanufacturing Partnership with Leading Pharmaceutical Company
From National Resilience, Inc.
Via Business Wire
Resilience Announces Equity Investment from Mubadala and Funding of New Biopharma Manufacturing Facility in the United Arab Emirates
From National Resilience, Inc.
Via Business Wire
Resilience Becomes Biomanufacturing Resource Partner for California Institute for Regenerative Medicine
From National Resilience, Inc.
Via Business Wire
Resilience Announces Collaboration to Manufacture and Deliver Biotherapeutics for Rare and Complex Conditions
From National Resilience, Inc.
Via Business Wire
The Parker Institute for Cancer Immunotherapy and Resilience Announce Strategic Alliance to Develop Next-Generation Cancer Therapies
From National Resilience, Inc.
Via Business Wire
Resilience Announces $625 Million Series D Financing to Expand Network, Bring Innovative Technologies to Biomanufacturing
From National Resilience, Inc.
Via Business Wire
Resilience and MD Anderson Launch Joint Venture to Accelerate Development and Manufacturing of Innovative Cell Therapies for Cancer
From National Resilience, Inc.
Via Business Wire
Resilience Establishes Multi-Product Development and Manufacturing Collaboration with Takeda’s Plasma-Derived Therapies Business Unit
From National Resilience, Inc.
Via Business Wire
Resilience Subsidiary Ology Bioservices Awarded Contract Worth Up To $250 Million from U.S. Department of Defense for Botulinum Neurotoxin Treatment
From National Resilience, Inc.
Via Business Wire
Resilience Acquires SwiftScale Biologics, a Leader in Cell-Free Protein Synthesis Technology
From National Resilience, Inc.
Via Business Wire
CORRECTING and REPLACING Resilience Joins Forces with Children’s Hospital of Philadelphia to Develop Next-Generation Biomanufacturing Technologies, Create Impactful Therapies
From National Resilience, Inc.
Via Business Wire
Resilience Joins Forces with Childen’s Hospital of Philadelpia to Develop Next-Generation Biomanufacturing Technologies, Create Impactful Therapies
From National Resilience, Inc.
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.